Economic benefit of back titration in the treatment of hypertension in Jos, Nigeria

Figures & data

Table 1 Cost benefit of back titration in study subjects

S. No.	Cost 1 (N)	Cost 2 (N)	Difference (N)	Difference (%)
1	68	2.25	65.75	98.5
2	21.50	5.82	15.68	72.9
3	25	3.57	21.43	85.7
4	179	170	9	5
5	152.50	95	57.50	37.7
6	65	0	65	100
7	165.50	161.64	3.86	2.3
8	424.50	212.25	212.25	50
9	110	42.50	67.50	61.4
10	50	25	25	50
11	42.50	0	42.50	100
12	57.14	0	57.14	100
13	185	12.50	172.50	93.2
14	215	75	140	65.1
15	161	80.50	80.50	50
16	60	30	30	50
17	150	10	140	93.3
18	69.50	65.64	3.86	5.6
19	232.50	190	42.5	18.3
20	188	160	28	14.9
21	80.50	53.93	26.57	33
22	85	75	10	11.8
23	85	12.14	72.86	85.7
24	34	14.07	19.93	58.6
25	11.43	0	11.43	100
26	181.50	102.50	79	43.5
27	40	20	20	50
28	70	45	25	35.7
29	171	80.50	90.50	52.9
30	85	42.50	42.50	50
31	25	0	25	100
32	185	115	70	37.8
33	77	25.50	51.50	66.9
34	3.57	1.79	1.78	49.9
35	94.50	17	77.50	82
36	82.50	78.64	3.86	4.7
37	32.50	18.57	13.93	42.9
38	21.25	6.07	15.18	71.4
39	275	80	195	70.9

Notes: Cost 1 refers to the cost of drugs before back titration. Cost 2 refers to the cost of drugs after back titration; the lowest cost still kept blood pressure under control.

Abbreviations: N, Nigerian Naira; S. No., serial number.